Fig. 1From: Association of HTRA1 and ARMS2 gene polymorphisms with response to intravitreal ranibizumab among neovascular age-related macular degenerative subjectsPCR and RFLP product for ARMS2 rs10490924 (a) and HTRA1 rs11200638 (b) gene polymorphisms on 2% agarose gel. RFLP product of ARMS2 rs10490924 (a): Lane 1 shows homozygous GG, 259Â bp and 190Â bp; lane 2 and lane 6 show heterozygous GT, 449Â bp, 259Â bp and 190Â bp; lane 3 until lane 5 show homozygous TT, 449Â bp. RFLP product of HTRA1 rs11200638 (b): lane 1, lane 4, lane 5 and lane 6 show homozygous AA, 385Â bp; lane 2 shows heterozygous GA, 385Â bp, 246Â bp and 139Â bp; lane 7 shows homozygous GG, 246Â bp and 139Â bpBack to article page